Lines of melanoma cells showed that the
co-promotion of F Raf and PI3K Akt mTOR PTEN Bosutinib SKI-606 and AKT pathways Raf dealt with mTOR inhibitors Born a synergistic inhibition. Treatment of lung cancer contains Lt inducible murine KRAS and PIK3CA mutations with PI3K and MEK inhibitors mTOR leads to a Erh Increase the response. Recent reports also synergistic reactions sorafenib and mTOR inhibitors have shown in human tumor xenografts highly metastatic HCC. A presentation to document the reasons for the orientation of these two paths is shown in Figure 3. The combined effects of the MEK inhibitor PD 0329501 and mTOR with rapamycin or its analogue AP 23 573 were examined in NSCLC human cell lines and in animal models of lung cancer in humans. PD 0325901 and rapamycin showed a synergistic inhibition of proliferation and protein translation.
Deletion of both MEK and mTOR inhibits ribosome biogenesis and was associated with a block in the initial phase of translation. These results support CP-690550 pr Clinical removing both WIPO and mTOR. Ways in the treatment of lung cancer, and show that the two paths converge to regulate the initiation of protein translation ERK MAPK kinases phosphorylated signal integration period and p90 ribosomal S6 kinase p90rsk which the activity of t Of eukaryotic translation initiation factor eIF4E to regulate. 4EBP1 phosphorylation in cells harboring the BRAF mutation changed ver. It should also be noted that by 4EBP1 Akt, mTOR and p70S6K are regulated. This can be in the efficient translation of specific mRNAs lead in BRAF mutant cells.
This k Nnte the inhibition of MEK and mTOR cooperation explained synergy Ren protein translation and the growth of certain cells of the lung cancer inhibiting. Improve the efficiency of Raf and MEK inhibitors mTOR PI3K with a herk Mmlichen Chemotherapy Chemotherapy is often the treatment of cancer at the h Most common prescribed for many types of cancer. Drugs such as doxorubicin and taxol are effective in the treatment of many types of cancer, although in some cases F Drug resistance developed by L Through prolonged treatment. Doxorubicin and taxol target cellular Re events such as DNA replication and cell division, which is often the downstream targets of inhibitors of the pathway of signal transduction. Chemotherapeutics k Can activate the Ras Raf MEK ERK by different mechanisms.
Drugs such as doxorubicin can activate p53 may lead to increased FITTINGS expression of the receptor Dom ne Disco Dine, which in turn entered dinner Raf MEK ERK pathway activation can result. Activated ERK can phosphorylate p53 and regulate their activity T. Doxorubicin k Can also calcium-dependent Calmodulin-dependent kinase cascade by reactive oxygen species. Activation of this cascade is also set dinner activation of Raf MEK ERK cascade. Activation of this cascade may entered dinner transcription of genes such as XRCC1 and ERCC1 are involved in DNA repair and resistance occurred dinner. Taxols can also stimulate ERK activation cascade Raf and MEK involved lead to increased FITTINGS association with proteins in cell division.